Patents by Inventor Hyun Bin Kang

Hyun Bin Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220246864
    Abstract: The present disclosure relates to a novel organic compound and an organic electroluminescent device including the same. More specifically, the present disclosure relates to a deuterated organic compound and an organic electroluminescent device including at least one organic layer made of the deuterated organic compound. Thus, the organic electroluminescent device exhibits a longer lifetime, lower voltage implementation, and improved luminous efficiency.
    Type: Application
    Filed: April 15, 2022
    Publication date: August 4, 2022
    Inventors: Seunghee Yoon, Inbum Song, Hyun Bin Kang, Jaemin Ryu, Jin Sung Kim, Tae-ho Kwak, Sunghoon Kim
  • Patent number: 11342505
    Abstract: The present disclosure relates to a novel organic compound and an organic electroluminescent device including the same. More specifically, the present disclosure relates to a deuterated organic compound and an organic electroluminescent device including at least one organic layer made of the deuterated organic compound. Thus, the organic electroluminescent device exhibits a longer lifetime, lower voltage implementation, and improved luminous efficiency.
    Type: Grant
    Filed: March 27, 2019
    Date of Patent: May 24, 2022
    Assignees: MATERIAL SCIENCE CO., LTD., LG DISPLAY CO., LTD.
    Inventors: Seunghee Yoon, Inbum Song, Hyun Bin Kang, Jaemin Ryu, Jin Sung Kim, Tae-Ho Kwak, Sunghoon Kim
  • Patent number: 11107993
    Abstract: The present invention relates to an organic light-emitting diode (OLED) including a novel organic compound used in a light emitting layer thereof. Particularly, the present invention relates to an OLED including a novel pyrene-based organic compound.
    Type: Grant
    Filed: December 29, 2016
    Date of Patent: August 31, 2021
    Inventors: Jae Ho Jeong, Hyun Bin Kang, Ji Woong Yoo, Sang Hoon Hong, In Kyung Jeong
  • Publication number: 20210053998
    Abstract: The present disclosure relates to an organic electroluminescent element, and more particularly to an organic electroluminescent element including a novel boron-based organic compound and anthracene-based organic compound in one or more organic layers included in the organic electroluminescent element. The present disclosure may provide an organic electroluminescent element, which is prevented from deterioration in color characteristics and has characteristics such as long lifetimes, as a result of using a host material having a specific structural formula despite having high polarity.
    Type: Application
    Filed: July 23, 2019
    Publication date: February 25, 2021
    Inventors: Sung Hoon KIM, Jae Ho JEONG, Hyun Bin KANG, Jin-sung KIM, Tae-ho KWAK
  • Publication number: 20200176679
    Abstract: The present invention relates to a compound represented by Formula 1 and an organic electroluminescent element including the same, and provides an organic compound which is excellent in service life, efficiency, electrochemical stability, and thermal stability, and an organic electroluminescent element including the same.
    Type: Application
    Filed: May 21, 2018
    Publication date: June 4, 2020
    Inventors: Jae Ho Jeong, Hyun Bin Kang, Jin Sung KIM, Tae Ho KWAK
  • Publication number: 20200028084
    Abstract: Disclosed is an organic electroluminescent device. More specifically, disclosed is an organic electroluminescent device comprising at least one organic layer comprising at least two dopant compounds therein. The electroluminescent device employs both of a boron-based dopant and a pyrene-based dopant to provide improved color characteristics, efficiency and lifespan.
    Type: Application
    Filed: July 18, 2019
    Publication date: January 23, 2020
    Applicants: LG Display Co., Ltd., Material Science Co., Ltd.
    Inventors: Inbum SONG, Seunghee YOON, Sang-Hoon HONG, Hyun Bin KANG, Jaemin RYU
  • Publication number: 20190305227
    Abstract: The present disclosure relates to a novel organic compound and an organic electroluminescent device including the same. More specifically, the present disclosure relates to a deuterated organic compound and an organic electroluminescent device including at least one organic layer made of the deuterated organic compound. Thus, the organic electroluminescent device exhibits a longer lifetime, lower voltage implementation, and improved luminous efficiency.
    Type: Application
    Filed: March 27, 2019
    Publication date: October 3, 2019
    Inventors: Seunghee Yoon, Inbum Song, Hyun Bin Kang, Jaemin Ryu, Jin Sung Kim, Tae-ho Kwak, Sunghoon Kim
  • Publication number: 20190006592
    Abstract: The present invention relates to an organic light-emitting diode (OLED) including a novel organic compound used in a light emitting layer thereof. Particularly, the present invention relates to an OLED including a novel pyrene-based organic compound.
    Type: Application
    Filed: December 29, 2016
    Publication date: January 3, 2019
    Inventors: Jae Ho JEONG, Hyun Bin KANG, Ji Woong YOO, Sang Hoon HONG, In Kyung JEONG
  • Patent number: 9085578
    Abstract: The present invention provides an agent for the prophylaxis or treatment of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus etc.) and the like, which has a superior Tyk2 inhibitory action. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
    Type: Grant
    Filed: February 19, 2013
    Date of Patent: July 21, 2015
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Hiroyuki Nagamiya, Masato Yoshida, Masaki Seto, Shogo Marui, Tsuneo Oda, Yuji Ishichi, Hideo Suzuki, Tomokazu Kusumoto, Takatoshi Yogo, Chul Yun Rhim, Cheolhwan Yoon, Gil Nam Lee, Hyun Bin Kang, Kwang Ok Kim, Hye Sun Jeon
  • Publication number: 20150045349
    Abstract: The present invention provides an agent for the prophylaxis or treatment of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus etc.) and the like, which has a superior Tyk2 inhibitory action. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
    Type: Application
    Filed: February 19, 2013
    Publication date: February 12, 2015
    Inventors: Hiroyuki Nagamiya, Masato Yoshida, Masaki Seto, Shogo Marui, Tsuneo Oda, Yuji Ishichi, Hideo Suzuki, Tomokazu Kusumoto, Takatoshi Yogo, Chul Yun Rhim, Cheolhwan Yoon, Gil Nam Lee, Hyun Bin Kang, Kwang Ok Kim, Hye Sun Jeon
  • Patent number: 8101781
    Abstract: The present invention relates to a process for the efficient preparation of highly optical pure chiral carvedilol. According to the present invention, a chiral oxazolidin-2-one or oxazolidin-2-thione having formula 2, produced from the reaction of N-protected 2-(2-methoxyphenoxy)ethylamine with a chiral glycidol derivative is used as a key intermediate for the preparation of the chiral carvedilol. Specifically, the process for the preparation of the chiral carvedilol comprises a) reacting a compound of formula 2 with a halogenation agent, a sulfonation agent or a mitsunobu reagent to activate a hydroxyl group of the compound of formula 2, followed by nucleophilic substitution reaction with 9H-4-hydroxy carbazole to produce a compound of formula 7, and b) subjecting the obtained compound of formula 7 to a deprotection reaction in a presence of an inorganic base to produce the targeted chiral carvedilol. The process of the present invention can be accomplished in a mild condition.
    Type: Grant
    Filed: August 31, 2006
    Date of Patent: January 24, 2012
    Assignees: AHN-Gook Pharmaceutical Co., Ltd., RSTech Corporation
    Inventors: Seong-Jin Kim, Chang Woo Jong, Hyun Bin Kang, Byung Hyun Moon, Long Guo Quan, Duk Kwon Won, Kyung Yong Jin
  • Publication number: 20090176992
    Abstract: The present invention relates to a process for the efficient preparation of highly optical pure chiral carvedilol. According to the present invention, a chiral oxazolidin-2-one or oxazolidin-2-thione having formula 2, produced from the reaction of N-protected 2-(2-methoxyphenoxy)ethylamine with a chiral glycidol derivative is used as a key intermediate for the preparation of the chiral carvedilol. Specifically, the process for the preparation of the chiral carvedilol comprises a) reacting a compound of formula 2 with a halogenation agent, a sulfonation agent or a mitsunobu reagent to activate a hydroxyl group of the compound of formula 2, followed by nucleophilic substitution reaction with 9H-4-hydroxy carbazole to produce a compound of formula 7, and b) subjecting the obtained compound of formula 7 to a deprotection reaction in a presence of an inorganic base to produce the targeted chiral carvedilol. The process of the present invention can be accomplished in a mild condition.
    Type: Application
    Filed: August 31, 2006
    Publication date: July 9, 2009
    Inventors: Seong-Jin Kim, Chang Woo Jong, Hyun Bin Kang, Byung Hyun Moon, Long Guo Quan, Duk Kwon Won, Kyung Yong Jin